Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Cardiol Therapeutics Inc T.CRDL

Alternate Symbol(s):  T.CRDL.W.A | CRDL

Cardiol Therapeutics Inc. (Cardiol) is a Canada-based clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). The Company's lead product, CardiolRx, is a pharmaceutically produced oral cannabidiol formulation that is in a Phase II/III study in hospitalized patients testing positive for COVID-19 with a prior history of, or risk factors for, cardiovascular disease. Cardiol has also received clearance from the Food and Drug Administration (FDA) for its investigational new drug (IND) application for a Phase II international trial that investigates the anti-inflammatory and anti- fibrotic properties of CardiolRx in patients with acute myocarditis, which is a common cause of sudden cardiac death in people under 35 years of age. In addition, Cardiol is developing a subcutaneous formulation of CardiolRx and other anti-inflammatory therapies for the treatment of chronic heart failure.


TSX:CRDL - Post by User

Post by Jordan1159on Apr 11, 2022 3:12pm
269 Views
Post# 34594609

Cardiol will run north in time no doubt

Cardiol will run north in time no doubtCardiol Therapeutics shares could go up in value very quickly here! With the world under a Covid umbrella that doesn't appear to folded up by mother nature anytime soon, Cardiol is in a position to be a game changer company that potentially could be bought out by a big pharma company - this wont surprise me. Cardiols CEO's last company had a 1 billion market cap!!!!!!! Very intelligent man, Dave Elsley, and is one of the main reasons im here - again!! Patients could be rewarded - get it? Check into them and draw your own conclusions.
<< Previous
Bullboard Posts
Next >>